Latest Earnings Results: Q3 '26
Estimated EPS
-$0.06
Reported EPS
$0.08
Surprise
+244.93%
Estimated Rev
$151.05M
Reported Rev
$154.45M
Surprise
+2.25%
• Reported GAAP EPS of $0.17 up 1800.00% YoY • Reported revenue of $154.45M up 15.03% YoY • AtriCure projects full year 2026 revenue of approximately $606M to $610M and adjusted EBITDA of approximately $91M to $94M; net income per share is expected at $0.21 to $0.27.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | -$0.02 | -- | -- | N/A |
Q3 '26 | -$0.06 | $0.08 | 244.93% | BEAT |
Q2 '26 | -$0.00 | $0.18 | 10846.27% | BEAT |
Q1 '26 | -$0.06 | $0.00 | 100.00% | BEAT |
Q4 '25 | -$0.09 | $0.04 | 146.10% | BEAT |